| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.
|
Anal Chem
|
2006
|
3.24
|
|
2
|
Establishing reporting standards for metabolomic and metabonomic studies: a call for participation.
|
OMICS
|
2006
|
2.72
|
|
3
|
The metabolomics standards initiative.
|
Nat Biotechnol
|
2007
|
2.54
|
|
4
|
Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research.
|
Metabolomics
|
2009
|
2.21
|
|
5
|
Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes.
|
PLoS One
|
2009
|
1.87
|
|
6
|
Metabolomics in human nutrition: opportunities and challenges.
|
Am J Clin Nutr
|
2005
|
1.85
|
|
7
|
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis.
|
Genome Biol
|
2007
|
1.80
|
|
8
|
Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.
|
PLoS One
|
2010
|
1.64
|
|
9
|
An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.
|
Am J Clin Nutr
|
2010
|
1.27
|
|
10
|
Exploring the benefits and challenges of establishing a DRI-like process for bioactives.
|
Eur J Nutr
|
2014
|
1.24
|
|
11
|
The case for strategic international alliances to harness nutritional genomics for public and personal health.
|
Br J Nutr
|
2005
|
1.24
|
|
12
|
Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.
|
PLoS One
|
2009
|
1.24
|
|
13
|
Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies.
|
Genes Nutr
|
2010
|
1.18
|
|
14
|
Nutritional systems biology modeling: from molecular mechanisms to physiology.
|
PLoS Comput Biol
|
2009
|
1.18
|
|
15
|
Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
|
Expert Rev Proteomics
|
2005
|
1.14
|
|
16
|
Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach.
|
Biochem Pharmacol
|
2003
|
1.10
|
|
17
|
Bromobenzene-induced hepatotoxicity at the transcriptome level.
|
Toxicol Sci
|
2004
|
1.07
|
|
18
|
Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status.
|
Metabolomics
|
2011
|
1.06
|
|
19
|
Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis.
|
Toxicol Pathol
|
2005
|
1.06
|
|
20
|
The Micronutrient Genomics Project: a community-driven knowledge base for micronutrient research.
|
Genes Nutr
|
2010
|
1.06
|
|
21
|
Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2.
|
Biochim Biophys Acta
|
2003
|
1.03
|
|
22
|
26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition.
|
Nutrition
|
2011
|
0.99
|
|
23
|
The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines.
|
Carcinogenesis
|
2003
|
0.97
|
|
24
|
High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells.
|
Am J Clin Nutr
|
2006
|
0.97
|
|
25
|
The challenges for molecular nutrition research 1: linking genotype to healthy nutrition.
|
Genes Nutr
|
2008
|
0.96
|
|
26
|
The NuGO proof of principle study package: a collaborative research effort of the European Nutrigenomics Organisation.
|
Genes Nutr
|
2008
|
0.96
|
|
27
|
Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2.
|
Cancer Lett
|
2005
|
0.93
|
|
28
|
Transcriptomic coordination in the human metabolic network reveals links between n-3 fat intake, adipose tissue gene expression and metabolic health.
|
PLoS Comput Biol
|
2011
|
0.93
|
|
29
|
Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice.
|
PLoS One
|
2013
|
0.92
|
|
30
|
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.
|
J Lipid Res
|
2009
|
0.92
|
|
31
|
Personalised nutrition: status and perspectives.
|
Br J Nutr
|
2007
|
0.91
|
|
32
|
Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study.
|
BMC Med Genomics
|
2010
|
0.89
|
|
33
|
Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro.
|
Eur J Nutr
|
2004
|
0.88
|
|
34
|
Nutrigenomics: the impact of biomics technology on nutrition research.
|
Ann Nutr Metab
|
2005
|
0.88
|
|
35
|
Consensus statement understanding health and malnutrition through a systems approach: the ENOUGH program for early life.
|
Genes Nutr
|
2013
|
0.88
|
|
36
|
Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges.
|
BMC Med Genomics
|
2013
|
0.87
|
|
37
|
Diagnostic markers based on a computational model of lipoprotein metabolism.
|
J Clin Bioinforma
|
2011
|
0.86
|
|
38
|
Developing computational model-based diagnostics to analyse clinical chemistry data.
|
Brief Bioinform
|
2010
|
0.86
|
|
39
|
Improving the analysis of designed studies by combining statistical modelling with study design information.
|
BMC Bioinformatics
|
2009
|
0.85
|
|
40
|
A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans.
|
J Lipid Res
|
2012
|
0.85
|
|
41
|
Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy.
|
PLoS One
|
2012
|
0.84
|
|
42
|
Looking back into the future: 30 years of metabolomics at TNO.
|
Mass Spectrom Rev
|
2013
|
0.84
|
|
43
|
A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice.
|
J Nutr
|
2011
|
0.83
|
|
44
|
How we will produce the evidence-based EURRECA toolkit to support nutrition and food policy.
|
Eur J Nutr
|
2008
|
0.83
|
|
45
|
White adipose tissue reference network: a knowledge resource for exploring health-relevant relations.
|
Genes Nutr
|
2014
|
0.83
|
|
46
|
Short-term fatty acid intervention elicits differential gene expression responses in adipose tissue from lean and overweight men.
|
Genes Nutr
|
2008
|
0.82
|
|
47
|
Toxicogenomic analysis of gene expression changes in rat liver after a 28-day oral benzene exposure.
|
Mutat Res
|
2005
|
0.82
|
|
48
|
Systems biology analysis unravels the complementary action of combined rosuvastatin and ezetimibe therapy.
|
Pharmacogenet Genomics
|
2012
|
0.81
|
|
49
|
Owner controlled data exchange in nutrigenomic collaborations: the NuGO information network.
|
Genes Nutr
|
2009
|
0.81
|
|
50
|
A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis.
|
BMC Syst Biol
|
2011
|
0.81
|
|
51
|
Harnessing Nutrigenomics: Development of web-based communication, databases, resources, and tools.
|
Genes Nutr
|
2006
|
0.80
|
|
52
|
Effects of high fat fish oil and high fat corn oil diets on initiation of AOM-induced colonic aberrant crypt foci in male F344 rats.
|
Food Chem Toxicol
|
2003
|
0.80
|
|
53
|
A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.
|
BMC Med Genomics
|
2014
|
0.79
|
|
54
|
Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations.
|
J Pharmacokinet Pharmacodyn
|
2014
|
0.79
|
|
55
|
Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: a toxicogenomics approach.
|
Drug Metab Dispos
|
2006
|
0.78
|
|
56
|
Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
|
Toxicol Appl Pharmacol
|
2005
|
0.78
|
|
57
|
Effect of body fat distribution on the transcription response to dietary fat interventions.
|
Genes Nutr
|
2009
|
0.78
|
|
58
|
Systematic construction of a conceptual minimal model of plasma cholesterol levels based on knockout mouse phenotypes.
|
Biochim Biophys Acta
|
2010
|
0.77
|
|
59
|
Dietary n-6 and n-3 polyunsaturated fatty acids and colorectal carcinogenesis: results from cultured colon cells, animal models and human studies.
|
Environ Toxicol Pharmacol
|
2002
|
0.77
|
|
60
|
Effects of n-6 and n-3 polyunsaturated fatty acids on gap junctional intercellular communication during spontaneous differentiation of the human colon adenocarcinoma cell line Caco-2.
|
Nutr Cancer
|
2002
|
0.76
|
|
61
|
The challenges for molecular nutrition research 3: comparative nutrigenomics research as a basis for entering the systems level.
|
Genes Nutr
|
2008
|
0.76
|
|
62
|
Next-Generation Biomarkers of Health.
|
Nestle Nutr Inst Workshop Ser
|
2016
|
0.76
|
|
63
|
A physiologically-based kinetic model for the prediction of plasma cholesterol concentrations in the mouse.
|
Biochim Biophys Acta
|
2011
|
0.76
|
|
64
|
The introduction of toxicogenomics; potential new markers of hepatotoxicity.
|
Cancer Biomark
|
2005
|
0.75
|